Search

Search bills, members, committees and pages...

HUMACYTE

17 federal lobbying filings, 2023 to 2026.

HUMACYTE is a client on 17 federal lobbying filings, 2023 to 2026, reporting $270K across them. regenerative medicine company Based in North Carolina.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

3 it has hired, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$100K
20256$120K
20245$40K
20234$10K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues15
MMMMedicare/Medicaid7
DEFDefense5

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
HUMACYTECAPITOL HILL CONSULTING GROUP2026 second_quarter$50KJul 21, 2026
HUMACYTECAPITOL HILL CONSULTING GROUP2026 first_quarter$50KApr 21, 2026
HUMACYTECAPITOL HILL CONSULTING GROUP2025 fourth_quarter$50KJan 20, 2026
HUMACYTECAPITOL HILL CONSULTING GROUP2025 third_quarter$50KOct 21, 2025
HUMACYTECAPITOL HILL CONSULTING GROUP2025 third_quarterOct 20, 2025
HUMACYTEG2G CONSULTING2025 third_quarterOct 15, 2025
HUMACYTEG2G CONSULTING2025 second_quarter$10KJul 13, 2025
HUMACYTEG2G CONSULTING2025 first_quarter$10KApr 21, 2025
HUMACYTEG2G CONSULTING2024 fourth_quarter$10KJan 19, 2025
HUMACYTEG2G CONSULTING2024 third_quarter$10KOct 14, 2024
HUMACYTEG2G CONSULTING2024 second_quarter$10KJul 19, 2024
HUMACYTEG2G CONSULTING2024 first_quarter$10KApr 18, 2024
HUMACYTEG2G CONSULTING2024 first_quarterFeb 8, 2024
HUMACYTEFEDERAL HEALTH POLICY STRATEGIES2023 second_quarterOct 20, 2023
HUMACYTEFEDERAL HEALTH POLICY STRATEGIES2023 second_quarterJul 20, 2023
HUMACYTEFEDERAL HEALTH POLICY STRATEGIES2023 first_quarter$10KApr 20, 2023
HUMACYTEFEDERAL HEALTH POLICY STRATEGIES2023 first_quarterApr 17, 2023